Cost-effectiveness of HARNESS-MRI protocol in focal drug-resistant epilepsy in a limited-resources country: An Egyptian study.


Journal

Clinical neurology and neurosurgery
ISSN: 1872-6968
Titre abrégé: Clin Neurol Neurosurg
Pays: Netherlands
ID NLM: 7502039

Informations de publication

Date de publication:
10 2023
Historique:
received: 31 05 2023
revised: 25 07 2023
accepted: 14 08 2023
medline: 9 10 2023
pubmed: 29 8 2023
entrez: 28 8 2023
Statut: ppublish

Résumé

The international league against epilepsy (ILAE) recommended the harmonized neuroimaging of epilepsy structural sequences (HARNESS-MRI) to improve the detection of epileptogenic lesions in patients with focal drug-resistant epilepsy (DRE). The application of this protocol is still limited in low-resource countries, mainly due to apparent high costs. We aimed to evaluate the cost-effectiveness of the HARNESS-MRI protocol in Egypt and highlighted our experience. Patients diagnosed with focal DRE at Cairo University epilepsy clinic underwent both conventional MRI (c-MRI) and HARNESS-MRI. Electro-clinical data were collected and analyzed. After the radiologists' initial diagnosis, a multidisciplinary team re-evaluated the MRI. Lesion detection rate and cost for detecting an extra lesion by HARNESS-MRI protocol were calculated. The study included 230 patients with focal DRE (146, 62% males and 91, 38% females), with a mean age of 20.5 years. Epileptogenic lesions detected by c-MRI and HARNESS-MRI before and after the board meeting were 40, 106, and 131 lesions, respectively (P < 0.001). Sixty-nine percent of the lesions detected by HARNESS-MRI were missed on c-MRI; most commonly were mesial temporal sclerosis (MTS) and Malformations of cortical development (MCDs). Thirty-seven MTS and 32 MCDs were detected with HARNESS-MRI, compared to only 6 and 3, respectively, detected on c-MRI (P < 0.001). HARNESS-MR protocol is more cost-effective than c-MRI in detecting MRI lesions; it can save about 42$ for detecting an extra lesion in MRI. The HARNESS-MRI protocol was cost-effective and highly recommended even in limited-resource countries for patients with focal DRE.

Identifiants

pubmed: 37639829
pii: S0303-8467(23)00362-1
doi: 10.1016/j.clineuro.2023.107946
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107946

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None of the authors has any conflict of interest. The authors have no disclosures to declare.

Auteurs

Nirmeen A Kishk (NA)

Neurology Department, Faculty of Medicine, Cairo University, Egypt.

Reham Shamloul (R)

Neurology Department, Faculty of Medicine, Cairo University, Egypt.

Mona K Moawad (MK)

Neurology Department, Faculty of Medicine, Cairo University, Egypt.

Hussein Hamdi (H)

Neurosurgery Department, Faculty of Medicine, Tanta University, Egypt.

Ahmed A Morsy (AA)

Neurosurgery Department, Faculty of Medicine, Zagazig University, Egypt.

Michael Baghdadi (M)

MSc of Radiology, Ministry of Health, Egypt.

Mina Rizkallah (M)

MSc of Radiology, Ministry of Health, Egypt.

Amani Nawito (A)

Neurophysiology Department, Faculty of Medicine, Cairo University, Egypt.

Mohammad Edrees Mohammad (ME)

Neurology Department, Faculty of Medicine, Cairo University, Egypt.

Rehab Magdy (R)

Neurology Department, Faculty of Medicine, Cairo University, Egypt. Electronic address: rehab.m.hassan@kasralainy.edu.eg.

Enas Alsayyad (E)

Neurology Department, Faculty of Medicine, Cairo University, Egypt.

Alshimaa S Othman (AS)

Neurology Department, Faculty of Medicine, Cairo University, Egypt.

Amr M Fouad (AM)

Neurology Department, Faculty of Medicine, Cairo University, Egypt.

Haytham Rizk (H)

Neurology Department, Faculty of Medicine, Cairo University, Egypt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH